Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of FKBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of FKBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Investment Strategies / Falling Knives
Unthreaded | Threaded | Whole Thread (7) |
Author: BreckHutHigh   😊 😞
Number: of 1166 
Subject: Re: Investor AB
Date: 03/12/26 12:01 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 1
Gemini (AI) Summary:

Investor AB (IVSBF/INVE-B) is Sweden's premier industrial holding company, often referred to as the "Berkshire Hathaway of the Nordics." Controlled by the Wallenberg family for over a century, the firm offers a unique blend of exposure to global blue-chip industrials, private equity, and venture capital.

Following the January 22, 2026, year-end earnings call, here is a comprehensive analysis of its viability as a long-term investment.

1. Business Model
Investor AB generates value through a three-pillar investment strategy:

Listed Companies (72% of Assets): Significant minority stakes in world-class Swedish giants including Atlas Copco, ABB, AstraZeneca, SEB, and Ericsson. Revenue is generated through dividends and long-term capital appreciation.

Patricia Industries (19% of Assets): A portfolio of wholly-owned, unlisted subsidiaries. Key holdings include Mölnlycke (medical solutions), Permobil (power wheelchairs), and the newly integrated Nova Biomedical.

Investments in EQT (9% of Assets): Ownership in EQT AB (the private equity firm) and limited partner investments in EQT funds. This provides exposure to high-growth, leveraged buyouts and infrastructure globally.

2. Financial Health (Last 3-5 Years)
Investor AB’s financial strategy is defined by low leverage and consistent dividend growth.

Net Asset Value (NAV) Growth: Adjusted NAV grew by 14% in 2025, reaching SEK 1,087 billion. The 5-year average total return (TSR) sits at a robust 19.4%, consistently outperforming the SIXRX benchmark.

Leverage (Net Debt/EBITDA): The company operates with very low leverage, ending 2025 at 2.1% (well within its <10% target). Interest coverage remains exceptionally high at over 42x.

Capital Allocation: Sound and disciplined. In 2025, they deployed SEK 29 billion into new investments, including increasing stakes in Ericsson and Atlas Copco during market dips, while raising the dividend by 8% to SEK 5.60.

3. Competitive Advantage
Investor’s "moat" is built on its Buy-and-Build philosophy and the Wallenberg Network.

The Network Moat: They provide portfolio companies with access to a global network of talent and industrial expertise that few competitors can match.

Pricing Power: Most of their listed holdings (Atlas Copco, AstraZeneca) possess "Wide Moat" status due to high switching costs and specialized technology.

vs. Competitors: Compared to Industrivärden (their closest Swedish rival), Investor AB is more diversified through its private equity arm (Patricia Industries). While Industrivärden focuses purely on listed Swedish large-caps, Investor’s unlisted portfolio provides a "valuation buffer" during public market volatility.

4. Growth Drivers & Industry Trends
The "MedTech" Pivot: Through Patricia Industries, Investor is aggressively expanding into healthcare. The acquisition of Nova Biomedical in 2025 is a key catalyst for 2026/2027 earnings growth.

AI and Automation: Their industrial holdings (ABB and Atlas Copco) are primary beneficiaries of the "Smart Factory" and AI-driven automation trends.

Headwinds: Global trade tensions and newly proposed tariffs (specifically targeting European exports to the US) remain a significant risk for their export-oriented industrial base.

5. Risks
Currency Volatility: As a Swedish company with global operations, a strengthening SEK significantly impacts the reported sales of Patricia Industries (which saw a -9% return in 2025 primarily due to FX).

Concentration Risk: The portfolio is heavily weighted toward a few key names (AstraZeneca and Atlas Copco). Any sector-specific downturn in Pharma or Industrial Capital Goods disproportionately affects NAV.

Regulatory Risk: Ongoing EU/US regulatory scrutiny on "dual-class" share structures (which the Wallenbergs use to maintain control) could theoretically impact valuation if governance rules tighten.

6. Valuation Context
Investor AB typically trades at a discount to its Net Asset Value (NAV).

Current Valuation: As of March 2026, the stock trades at approximately SEK 350, implying a ~12-15% discount to its adjusted NAV per share of SEK 355.

Multiples: Its forward P/E of ~7x and EV/EBITDA of 1.6x are historically low, reflecting the "holding company discount." However, compared to its 5-year median P/E of 4.6x, it currently looks slightly "expensive" on a pure earnings basis, though justified by the higher-quality private portfolio.

7. Bull/Bear Case (3-Year Outlook)
Bull Case (Target: SEK 500+)

Catalyst: A successful IPO of Mölnlycke or a major valuation step-up in EQT funds.

Scenario: Global interest rates stabilize, fueling a new M&A cycle for EQT. Patricia Industries achieves its 10% organic growth target, and the NAV discount narrows to <5% as international investors seek "Safe Haven" industrial quality.

Bear Case (Target: SEK 280-310)

Catalyst: Escalating global trade war and US-EU tariffs.

Scenario: A deep recession in the Eurozone and China hits Atlas Copco and ABB orders. The USD weakens significantly against the SEK, causing Patricia Industries' margins to contract. The NAV discount widens to 25% as risk-off sentiment prevails.

Final Assessment
Investor AB is a "Core Holding" candidate. It is a viable long-term investment for those seeking diversified industrial exposure with a built-in "active management" layer. Its resilience in 2025 despite FX headwinds suggests a robust floor for the stock.
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to BreckHutHigh here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 562 posts about Non-US Stocks. The article-length ones it recommended most:
Greggs PLC (GRG.L) · 20 recs · 2025
Topicus: Not Constellation · 16 recs · 2026
Unite Group (UTG), UK, falling knife. · 13 recs · 2025
SKAN · 11 recs · 2025
MELI - Brazilian darling · 10 recs · 2025
Unthreaded | Threaded | Whole Thread (7) |


Announcements
Falling Knives FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of FK | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community